Beta Drugs Limited
NSE: BETA
Beta Drugs Limited is an Indian listed company, traded under NSE: BETA (ISIN INE351Y01019).
It has a market capitalisation of ₹1,743 crore, a last close of ₹1,720 on 2026-10-19, a one-year return of -3.8%.
Valuation: a price-to-earnings ratio of 42.02x, a price-to-book ratio of 7.12x, a dividend yield of 0.0%.
Profitability: return on equity of 18.8%, return on capital employed of 19.3%, an operating margin of 19.7%.
Balance sheet and ownership: debt-to-equity of 0.60x, promoter holding of 58.9%.
| Metric | Value |
|---|---|
| Market capitalisation | 1,743 |
| Last close | ₹1,720 |
| P/E (TTM) | 42.02x |
| P/B | 7.12x |
| Dividend yield | 0.0% |
| ROE (FY) | 18.8% |
| ROCE (FY) | 19.3% |
| Operating margin (TTM) | 19.7% |
| Debt / equity | 0.60x |
| Promoter holding | 58.9% |
| 1-year return | -3.8% |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means